CRYSTAL FORM S4 OF THE PLK4 INHIBITOR (1R,2S)-(E)-2-(3-(4-((CIS-2,6-DIMETHYLMORPHOLINO)METHYL)STYRYL)- 1 H-IMIDAZOL-6- YL)-5'-METHOXYSPIRO[CYCLOPROPANE-1,3'-INDOLIN]-2'-ONE FUMARATE

#5 | 2022-03-24

US20220089601A1

Chemistry; metallurgy

Solid forms of TTK inhibitor

#6 | 2022-01-06

US20220002313A1

Chemistry; metallurgy

HPK1 INHIBITORS AND METHODS OF USING SAME

#7 | 2021-08-26

US20210261554A1

Chemistry; metallurgy

RIPK2 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

#8 | 2021-01-14

US20210009595A1

Chemistry; metallurgy

PYRAZOLOPYRIMIDINE COMPOUNDS

#9 | 2020-08-27

US20200270259A1

Chemistry; metallurgy

Solid forms of TTK inhibitor

#10 | 2020-06-18

US20200190104A1

Chemistry; metallurgy

HPK1 inhibitors and methods of using same

#11 | 2019-10-24

US20190322669A1

Chemistry; metallurgy

PYRAZOLOPYRIMIDINE COMPOUNDS

#12 | 2019-09-26

US20190292193A1

Chemistry; metallurgy

Solid forms of TTK inhibitor

#13 | 2019-07-25

US20190225617A1

Chemistry; metallurgy

RIPK2 inhibitors and method of treating cancer with same

#14 | 2019-02-07

US20190040074A1

Chemistry; metallurgy

Pyrazolopyrimidine compounds

#15 | 2018-10-04

US20180282335A1

Chemistry; metallurgy

RIPK2 inhibitors and method of treating cancer with same

#16 | 2018-10-04

US20180282306A1

Chemistry; metallurgy

Kinase inhibitors and method of treating cancer

#17 | 2018-06-28

US20180179221A1

Chemistry; metallurgy

HPK1 inhibitors and methods of using same

#18 | 2018-04-19

US20180105511A1

Chemistry; metallurgy

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

#19 | 2017-11-09

US20170320881A1

Chemistry; metallurgy

Pyrazolopyrimidine compounds

#20 | 2017-08-10

US20170226088A1

Chemistry; metallurgy

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

#21 | 2017-08-03

US20170217966A1

Chemistry; metallurgy

Pyrazolopyrimidine compounds

#22 | 2016-05-19

US20160137651A1

Chemistry; metallurgy

Pyrazolopyrimidine compounds

#23 | 2016-02-18

US20160045511A1

Human necessities

Kinase inhibitors and method of treating cancer

#24 | 2015-10-22

US20150299203A1

Chemistry; metallurgy

Pyrazolopyrimidine compounds

#25 | 2015-05-14

US20150133677A1

Chemistry; metallurgy

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

#26 | 2014-12-18

US20140371202A1

Chemistry; metallurgy

Indazole compounds as kinase inhibitors and method of treating cancer with same

#27 | 2014-02-20

US20140051679A1

Chemistry; metallurgy

KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

#28 | 2014-02-13

US20140045838A1

Chemistry; metallurgy

Kinase inhibitors and method of treating cancer

#29 | 2014-02-13

US20140045822A1

Human necessities

Kinase inhibitors and method of treating cancer with same

#30 | 2014-01-02

US20140005167A1

Chemistry; metallurgy

Kinase inhibitors and method of treating cancer with same

#31 | 2013-04-18

US20130096301A1

Chemistry; metallurgy

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

#32 | 2012-10-18

US20120264800A1

Chemistry; metallurgy

Kinase inhibitors and method of treating cancer

#33 | 2012-06-14

US20120149686A1

Human necessities

Kinase inhibitors and method of treating cancer with same

#34 | 2011-10-27

US20110263598A1

Chemistry; metallurgy

Kinase inhibitors and method of treating cancer

#35 | 2011-03-17

US20110065702A1

Chemistry; metallurgy

Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer

InventorID:

199408 ⎘